Abstract
BackgroundOX40 (CD134) is a costimulatory molecule of the tumor necrosis factor receptor superfamily that is currently being investigated as a target for cancer immunotherapy. However, despite promising results in murine...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have